Dr Joseph J Fantony, MD | |
2817 Rock Merritt Avenue, Fort Liberty, NC 28310-0001 | |
(910) 907-8528 | |
Not Available |
Full Name | Dr Joseph J Fantony |
---|---|
Gender | Male |
Speciality | Urology |
Location | 2817 Rock Merritt Avenue, Fort Liberty, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093064149 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 201500795 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joseph J Fantony, MD 2817 Rock Merritt Avenue, Fort Liberty, NC 28310-0001 Ph: (910) 907-8528 | Dr Joseph J Fantony, MD 2817 Rock Merritt Avenue, Fort Liberty, NC 28310-0001 Ph: (910) 907-8528 |
News Archive
Affymetrix, Inc. today announced the launch of the Affymetrix® MIP Copy Number Service, designed for cancer researchers using challenging FFPE samples. With the MIP Copy Number Service, scientists can now obtain high-quality allele-specific copy number data from FFPE samples. The service is available for research use only exclusively through the Affymetrix® Research Services Laboratory (ARSL).
New data confirm that subcutaneous injection of the innovative new anti-anemia agent CERA (Continuous Erythropoietin Receptor Activator) delivers rapid, sustained and stable correction of anemia in a broad spectrum of patients with chronic kidney disease at dosing intervals of up to 4 weeks.
University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has enabled them to identify small molecules that can inhibit adhesion and invasion, preventing ovarian cancers from spreading to nearby tissues.
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
› Verified 9 days ago